ArticleGenes & genomics2026
Transcriptomic profiling suggests restoration of epidermal barrier-associated lipid metabolism in Egr1-deficient skin following house dust mite exposure.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundHouse dust mite (HDM) is a major environmental allergen that promotes cutaneous inflammation and disrupts epidermal barrier-associated processes. Early growth response 1 (EGR1) is an inducible transcription factor implicated in inflammatory skin responses; however, its relationship with epidermal barrier-associated lipid metabolism during allergen exposure remains poorly understood.
objectiveThis study investigated whether Egr1 deficiency is associated with preservation of epidermal barrier-related features and restoration of lipid metabolic transcriptional programs following HDM exposure.
methodsEpidermal alterations and filaggrin (FLG) expression were evaluated in wild-type (WT) and Egr1-knockout (KO) mice following topical HDM exposure. A previously generated RNA-seq dataset from WT and Egr1-KO skin with or without HDM treatment was reanalyzed as an exploratory transcriptomic dataset. Expression-change profiling, functional enrichment, and gene set enrichment analyses were used to identify HDM-responsive transcriptional patterns associated with Egr1 deficiency. Selected lipid metabolism-associated genes were independently examined by quantitative real-time PCR.
resultsHDM exposure induced epidermal abnormalities and markedly reduced FLG expression in WT mice, whereas these changes were attenuated in Egr1-KO mice. Exploratory transcriptomic profiling suggested that Egr1 deficiency reprogrammed, rather than globally suppressed, the transcriptional response to HDM. Genes suppressed by HDM but restored in Egr1-deficient skin were preferentially associated with lipid metabolic processes, including fatty acid and sphingolipid metabolism. Gene set enrichment analysis further showed reciprocal enrichment of several lipid-related pathways between WT-HDM versus WT-control and KO-HDM versus WT-HDM comparisons. Independent expression analysis supported the recovery of Elovl6, Hacd2, and Cidec in HDM-treated Egr1-KO skin.
conclusionEgr1 deficiency is associated with attenuation of HDM-induced FLG loss and restoration of selected epidermal lipid metabolism-associated transcriptional patterns. These findings suggest that EGR1-associated inflammatory responses may intersect with epidermal lipid metabolism during allergen exposure and provide a basis for further investigation of EGR1 in the inflammation-barrier interface.
Indexed as
Identifiers
42905353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.